Recombinant KRT20 antibody (AA 196-323)

Catalog No. ABIN7871714

This Rabbit Monoclonal antibody specifically detects KRT20 in WB and IHC (p). It exhibits reactivity toward Human.

Quick Overview for Recombinant KRT20 antibody (AA 196-323) (ABIN7871714)

Target: KRT20 (Keratin 20 (KRT20))

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Rabbit

Clonality: Monoclonal

Conjugate: This KRT20 antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Grade: Carrier-free

Clone: KRT20-3129R

Product Details anti-KRT20 Antibody

Binding Specificity: AA 196-323

Purpose: Recombinant CK20 Antibody / Cytokeratin 20 (azide and preservative free)

Purification: Protein A affinity chromatography

Immunogen: A recombinant human partial protein (amino acids 196-323) was used as the immunogen for this Cytokeratin 20 antibody.

Isotype: IgG

Application Details

Application Notes: Optimal dilution of the recombinant CK20 antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Preservative: Azide free

Storage: 4 °C,-20 °C

Storage Comment: Store the recombinant CK20 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Target Details for KRT20

Target: KRT20 (Keratin 20 (KRT20))

Alternative Name: CK20

Background: This MAb recognizes an intermediate filament protein of 46 kDa, identified as cytokeratin 20 (KRT20). KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions.It has been detected in adenocarcinomas of the colon, stomachand biliary tract. Breast carcinomas are generally non-reactive.

UniProt: P35900